Skip to main navigation Skip to search Skip to main content

A Randomized, Multi-Center, Parallel Group, Single-Dose, Pharmacokinetics and Pharmacodynamics Study of Depagliflozin in Children and Adolescents Age 10 to 17 Years with Type 2 Diabetes Mellitus

Project: Research

Project Details

StatusFinished
Effective start/end date08/6/1308/5/15

Funding

  • Bristol Myers Squibb Company: $30,338.00